Prediction of Childhood Epilepsy Outcome in Bangladesh

NCT ID: NCT00381537

Last Updated: 2006-12-25

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

92 participants

Study Classification

INTERVENTIONAL

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Randomised controlled trial of the use of phenobarbitone and carbamazepine in childhood epilepsy in Bangladesh with particular reference to behavioural side effects.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Epilepsy

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

childhood epilepsy Active childhood epilepsy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Blinding Strategy

NONE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

phenobarbitone

Intervention Type DRUG

carbamazepine

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Active epilepsy
* Aged 2-15 years

Exclusion Criteria

* Excluded absence
* Myoclonic and malignant epilepsy syndromes
* Major motor and cognitive impairments
* Those currently receiving antiepilepsy drugs.
Minimum Eligible Age

2 Years

Maximum Eligible Age

16 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Institute of Child Health

OTHER

Sponsor Role lead

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Brian Neville, Professor

Role: PRINCIPAL_INVESTIGATOR

Institute of Child Health

Selina Banu, Dr

Role: PRINCIPAL_INVESTIGATOR

Children's Hospital Dhaka (Shishu) Bangladesh.

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Children's Hospital Dhaka (Shishu) Bangladesh.

Sher-e-Bangla Nagar, Dhaka 1207, , Bangladesh

Site Status

Institute of Child Health

London, , United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Bangladesh United Kingdom

References

Explore related publications, articles, or registry entries linked to this study.

Banu SH, Jahan M, Koli UK, Ferdousi S, Khan NZ, Neville B. Side effects of phenobarbital and carbamazepine in childhood epilepsy: randomised controlled trial. BMJ. 2007 Jun 9;334(7605):1207. doi: 10.1136/bmj.39022.436389.BE. Epub 2006 Dec 4.

Reference Type DERIVED
PMID: 17145735 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

99NR58

Identifier Type: -

Identifier Source: org_study_id